topic

1365 An immunocytokine with target cell-restricted IL-15 activity for induction of anti-tumor immunity against acute myeloid leukemia
Martina S Lutz, Bastian Schmied, Fabian Riegg, Latifa Zekri, Melanie Märklin, Martin Pflügler, Gundram Jung, Helmut R Salih

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1521; DOI: 10.1136/jitc-2023-SITC2023.1365
1366 B7-H3xCD3 bispecific antibody as novel treatment option in HER2-negative breast cancer
Martina S Lutz, Laura Weßling, Latifa Zekri, Christian M Tegeler, Ilona Hagelstein, Gundram Jung, Helmut R Salih

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1522; DOI: 10.1136/jitc-2023-SITC2023.1366
1367 A rational approach to selecting CD3-binding antibodies for T-cell engager development
Juntao (Matt) Mai, Valentine de Puyraimond, Philippe Pouliot, Kate Caldwell, Lauren Clifford, Allison Goodman, Patrick Farber, Patrick Rowe, Harveer Dhupar, Janice Reimer, Karine Herve, Vivian Li, Irene Yu, John Marwick, Nathalie Blamey, Melissa Cid, Cindy-Lee Crichlow, Lena M Bolten, Tova Pinsky, Gesa Volkers, Jessica Fernandes Scortecci, Girija Bodhankar, Caitlyn De Jong, Sophie Cullen, Ping Xiang, Ahn Lee, Gabrielle Conaghan, Antonios Samiotakis, Stefan Hannie, Rhys Chappell, Emma Lathouwers, Lauren Chong, Kate Gibson, Stephanie K Masterman, Kirstin Brown, Mark Fogg, Raffi Tonikian, Tim Jacobs, Aaron Yamniuk, Bryan C Barnhart

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1523; DOI: 10.1136/jitc-2023-SITC2023.1367
1368 Preclinical development of an agonistic anti-TNFR2 antibody (BI-1910) for cancer immunotherapy
Linda Martensson, Petra Holmkvist, Mathilda Kovacek, Carolin Svensson, Mimoza Bodén, Kirstie Cleary, Osman Dadas, Therese Blidberg, Benjamin Duell, Monika Semmrich, Jan Anders Nilsson, Stephen Beers, Sean Lim, Johan E Wallin, Marie Borggren, Andres McAllister, Mark Cragg, Ingrid Karlsson, Bjorn Frendeus, Ingrid Teige

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1524; DOI: 10.1136/jitc-2023-SITC2023.1368
1369 Abstract withdrawn
Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1525; DOI: 10.1136/jitc-2023-SITC2023.1369
1370 Anti-PD-1/IL-7v immunocytokine favors proliferation & survival of TCF1+ stem like memory T cells and a durable in vivo efficacy in monotherapy or using combinatorial strategy
Aurore Morello, Justine Durand, Margaux Seite, Isabelle Girault, Geraldine Teppaz, Virginie Thepenier, Cecile Batty, Ariane Desselle, Emmanuelle Wilhelm, Marine Malloci, Caroline Mary, Nicolas Poirier

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1526; DOI: 10.1136/jitc-2023-SITC2023.1370
1371 Novel orally active and high tissue penetrant small molecules targeting surface and intracellular PD-L1 signals for cancer immunotherapy
Nonthaneth Nalinratana, Niphat Jirapongwattana, Udomsak Udomnilobol, Songkiat Songthammanuphap, Eakkaphon Rattanangkool, Nopparat Thavornsin, Sirikan Deesiri, Jakkrit Srisa, Jakapun Soponpong, Supanan Ampawa, Chayan Charoenpakdee, Wilasinee Dunkoksung, Tanachote Ruengsatra, Supranee Buranapraditkun, Tirayut Vilaivan, Trairak Pisitkun, Nattiya Hirankarn, Thomayant Prueksaritanont

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1527; DOI: 10.1136/jitc-2023-SITC2023.1371
1372 TriTCE Co-Stim: a novel trispecific T cell engager platform, with integrated CD28 costimulation, engineered to widen the therapeutic window for treatment of poorly infiltrated tumors
Lisa Newhook, Purva Bhojane, Peter Repenning, Desmond Lau, Nichole Escalante, Diego Perez Escanda, Polly Shao, Maya Poffenberger, Alec Robinson, Kesha Patel, Alexandra Livernois, Chayne L Piscitelli, Nicole Afacan, Thomas Spreter von Kreudenstein, Nina Weisser

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1528; DOI: 10.1136/jitc-2023-SITC2023.1372
1373 SynBAd, a clinical cancer vaccine candidate, induces antigen-specific T cells and extends life in a therapeutic liver cancer model
Kayvan R Niazi, Peter A Sieling, Shahrooz Rabizadeh, Steve Benz, Justin Golovato, Aleece Nolasco

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1529; DOI: 10.1136/jitc-2023-SITC2023.1373
1374 Virus-like DNA, a single-agent poly-functional therapeutic platform that potently activates anti-cancer protective immunity
Kayvan R Niazi, Peter A Sieling, Steve Benz, Justin Golovato, Shahrooz Rabizadeh

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1530; DOI: 10.1136/jitc-2023-SITC2023.1374

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages